Associate Professor of Surgery
Brigham and Women's Hospital
Boston, Massachusetts
Dr. Matthew Menard graduated summa cum laude, phi beta kappa and with departmental high honors from Middlebury College. He attended Harvard Medical School (HMS) and received his general surgery training at the Massachusetts General Hospital (MGH) and vascular surgery fellowship training at the Brigham and Women’s Hospital (BWH). He is currently Co-Director of Endovascular Surgery and past Vascular Surgery Fellowship Director at BWH and is an Associate Professor of Surgery at HMS. His clinical practice spans the gamut of vascular surgical disease, with a focus on chronic limb threatening ischemia (CLTI).
Dr. Menard conceived and is a National Principal Investigator of the BEST-CLI Trial, an NIH-sponsored and FDA-endorsed investigation of the comparative-effectiveness of open surgery and endovascular therapy for CLTI. BEST-CLI is a randomized, controlled trial examining treatment efficacy, functional outcomes, cost and cost-effectiveness associated with endovascular or open surgical revascularization in patients with CLTI. Dr. Menard was the IDE holder and communicating PI of the Clinical Coordinating Center, based at the Brigham and Women’s Hospital. The results of the trial, which involved more than 150 clinical sites in the United States, Canada, Finland, Italy and New Zealand, were published in the New England Journal of Medicine. Dr. Menard, along with collaborators at Boston Medical Center, MGH and Kolding/Lillebælt Hospital in Denmark, recently received a $4 million grant from the Novo Nordisk Foundation to extend the analysis of this landmark trial, establish a core angiographic imaging laboratory at BWH and investigate the health economics of CLTI care globally.
C18: Infrainguinal Bypass—How to do it Successfully and Efficiently
Friday, June 21, 2024
1:30 PM – 3:00 PM CT
Bypass Using Prosthetic Conduit
Friday, June 21, 2024
2:05 PM – 2:12 PM CT